Country | : Spain ![]() |
Sector | : Pharma / Smaller Pharma |
Market Cap | : 1,176 (M€) |
Score (0-10) | Sector avg | Ranking out of 440 | |||
---|---|---|---|---|---|
Sustainability | 3.7 | 5.5 | 480 | ||
Our approach is based on analytical items contributing to the E, the S and the G, that can be highlighted as sustainability precursors and can be combined in an intellectually acceptable way. | |||||
Governance | 5.2 | 5.4 | 424 | ||
Board independence? | No | ||||
Splitting CEO and chairman roles? | No | ||||
+10 other Governance metrics | |||||
Social | 4.0 | 6.2 | 544 | ||
Are accident at work declining? | No | ||||
Wage dispersion trend vs peers | 0 / 10 | ||||
+22 other Social metrics | |||||
Environment | 6.0 | 7.2 | 219 | ||
Emission or consumption per € of capital employed on :
► Energy ► CO2 emissions ► Waste ► Water withdrawal |
|||||
ESG impact on target price | -3.2% |
-0.1% | 466 |
Company | Sustainability | Ranking |
---|---|---|
![]() |
3.7 | 480 |
![]() |
4.5 | 396 |
![]() |
6.4 | 131 |
![]() |
5.3 | 286 |
![]() |
5.1 | 315 |
![]() |
6.4 | 124 |
![]() |
6.9 | 66 |
Learn more on our methodology : | |
Access for issuers : | |
To AlphaValue research platform: |